Multimodal Imaging Trends and Forecast
The future of the global multimodal imaging market looks promising with opportunities in the brain & neurology, cardiology, oncology, ophthalmology, and research markets. The global multimodal imaging market is expected to reach an estimated $3.72 billion by 2030 with a CAGR of 4.7% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases, growing focus on personalized medicine, and on-going technological advancements in diagnostic imaging modalities.
• Lucintel forecasts that, within the Technology category, PET/CT will remain the largest segment over the forecast period due to increasing fundings for the multimodal systems and growing need for better turnaround time, high-image resolution, and real-time image guidance during surgeries.
• In terms of regions, North America will remain the largest region over the forecast period due to presence of robust healthcare infrastructure, increasing cases of chronic diseases and rising healthcare expenditure in the region.
A more than 150-page report is developed to help in your business decisions.
Emerging Trends in the Multimodal Imaging Market
The multimodal imaging market is witnessing several emerging trends that are shaping its future growth and development.
• AI and machine learning integration: The incorporation of AI and machine learning in imaging systems is enhancing diagnostic accuracy and automating image analysis, leading to quicker and more reliable results.
• Hybrid imaging systems: The development of hybrid imaging systems, such as PET/CT and PET/MR, is providing comprehensive diagnostic information by combining multiple imaging modalities.
• Portable and point-of-care systems: Innovations in portable and point-of-care multimodal imaging systems are making advanced diagnostics more accessible in remote and underserved areas.
• Personalized medicine: Multimodal imaging is playing a crucial role in personalized medicine by enabling precise diagnosis and monitoring of treatment responses.
• Regulatory approvals and certifications: Increased regulatory approvals and certifications for new multimodal imaging devices are facilitating their entry into the market and expanding their adoption.
• Collaborative research initiatives: Partnerships between academic institutions, healthcare providers, and technology companies are driving research and development, leading to innovative imaging solutions.
These emerging trends indicate a positive trajectory for the multimodal imaging market, with advancements in technology and increasing adoption driving growth and enhancing diagnostic capabilities.
Recent Developments in the Multimodal Imaging Market
The multimodal imaging market has seen several recent developments aimed at improving diagnostic accuracy and expanding access to advanced imaging technologies.
• AI-enhanced imaging systems: The development of AI-enhanced imaging systems is significantly improving the accuracy and efficiency of diagnostic procedures.
• Portable imaging solutions: Innovations in portable multimodal imaging solutions are making it easier to conduct advanced diagnostics in various healthcare settings, including remote and underserved areas.
• Advanced hybrid systems: The introduction of advanced hybrid imaging systems, such as PET/CT and PET/MR, is providing comprehensive diagnostic information and improving patient outcomes.
• Collaborative research and development: Increased collaboration between healthcare providers, research institutions, and technology companies is driving the development of innovative imaging solutions.
• Regulatory approvals: Recent regulatory approvals for new multimodal imaging devices are facilitating their market entry and increasing their adoption in clinical practices.
• Government initiatives and funding: Government initiatives and funding for healthcare infrastructure are supporting the adoption of advanced multimodal imaging systems in hospitals and clinics.
These recent developments are enhancing the capabilities of multimodal imaging systems, leading to improved diagnostic accuracy and expanded access to advanced imaging technologies.
Strategic Growth Opportunities for Multimodal Imaging Market
There are several strategic growth opportunities in the multimodal imaging market, particularly in key applications such as oncology, neurology, and cardiology.
• Oncology diagnostics: Investing in multimodal imaging systems for oncology diagnostics can significantly improve the detection and monitoring of cancers, leading to better patient outcomes.
• Neurological imaging: The use of multimodal imaging in neurology can enhance the diagnosis and treatment of neurological disorders, providing comprehensive insights into brain function and structure.
• Cardiology applications: Multimodal imaging systems are crucial in cardiology for diagnosing and monitoring heart diseases, offering detailed information on cardiac anatomy and function.
• Personalized treatment plans: Integrating multimodal imaging into personalized medicine approaches can improve the accuracy of treatment plans and monitor patient responses more effectively.
• Research and clinical trials: Multimodal imaging systems play a vital role in research and clinical trials, providing precise and comprehensive data for developing new treatments and therapies.
• Healthcare infrastructure development: Expanding the availability of multimodal imaging systems in hospitals and clinics can enhance overall healthcare services and improve diagnostic capabilities.
These strategic growth opportunities highlight the potential for significant advancements in the multimodal imaging market, improving diagnostic accuracy and patient care across various medical fields.
Multimodal Imaging Market Driver and Challenges
The multimodal imaging market is driven by several factors, but it also faces challenges that need to be addressed for sustained growth.
Drivers for the multimodal imaging market:
• Rising prevalence of chronic diseases: The increasing incidence of chronic diseases, such as cancer and cardiovascular disorders, is driving the demand for advanced diagnostic imaging systems.
• Technological advancements: Innovations in imaging technology are enhancing the capabilities and accuracy of multimodal imaging systems, making them more attractive to healthcare providers.
• Government support and funding: Government initiatives and funding for healthcare infrastructure are facilitating the adoption of advanced imaging technologies in hospitals and clinics.
Challenges for the multimodal imaging market:
• Growing awareness and education: Increased awareness about the benefits of early diagnosis and the use of advanced imaging systems is leading to higher adoption rates.
• High cost of advanced systems: The high cost of multimodal imaging systems can be a barrier to adoption, especially in developing regions.
• Limited access in underserved areas: Limited access to advanced healthcare facilities and trained professionals in rural and underserved areas poses a challenge to market growth.
While the multimodal imaging market is driven by several positive factors, addressing the challenges related to cost and access is crucial for achieving sustained growth and improving diagnostic capabilities.
List of Multimodal Imaging Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies multimodal imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the multimodal imaging companies profiled in this report include-
• Neusoft Medical Systems
• Ge Healthcare
• United Imaging Healthcare
• Mediso Medical Imaging
• Siemens Healthineers
• Spectrum Dynamics Medical
• Canon
• Koninklijke Philips N.V.
• Topcon Corporation
• Infraredx
Multimodal Imaging by Segment
The study includes a forecast for the global multimodal imaging by technology, application, end use industry, and region.
Multimodal Imaging Market by Technology [Analysis by Value from 2018 to 2030]:
• PET/CT
• PET/MR
• SPECT/CT
• OCT/FMT
• Others
Multimodal Imaging Market by Application [Analysis by Value from 2018 to 2030]:
• Brain & Neurology
• Cardiology
• Oncology
• Ophthalmology
• Research Applications
• Others
Multimodal Imaging Market by End Use Industry [Analysis by Value from 2018 to 2030]:
• Hospitals
• Diagnostic Imaging Centers
• Research and Academic Institutes
• Others
Multimodal Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Multimodal Imaging Market
Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. The content below highlights recent developments by multimodal imaging producers in key regions: the USA, UK, Germany, India, and China.
• United States: In the United States, the multimodal imaging market has seen significant advancements due to increased investments in healthcare technology and research. Leading institutions are adopting PET/MR and PET/CT systems for advanced diagnostics and research purposes. Companies are also focusing on developing AI-enhanced imaging software to improve diagnostic accuracy and workflow efficiency. Recent FDA approvals for new multimodal imaging devices are further boosting the market, while collaborations between healthcare providers and technology companies are driving innovation.
• Germany: Germany is a key player in the multimodal imaging market, with substantial investments in research and development. The country is focusing on integrating multimodal imaging systems in clinical practices to enhance patient care. German companies are at the forefront of developing cutting-edge technologies, such as hybrid PET/CT and SPECT/CT systems. Government support for healthcare infrastructure and initiatives to promote advanced medical technologies are propelling the market forward. Additionally, partnerships between academic institutions and industry leaders are fostering innovation in multimodal imaging.
• China: China’s multimodal imaging market is expanding rapidly, driven by the governmentÄX%$%Xs efforts to modernize healthcare infrastructure and increase access to advanced diagnostic tools. Recent developments include the introduction of cost-effective multimodal imaging systems tailored to the local market. Chinese manufacturers are focusing on producing affordable yet high-quality PET/CT and PET/MR systems. Collaborations with international companies and research institutions are helping to bring the latest technologies to the Chinese market, enhancing diagnostic capabilities in hospitals and clinics.
• Japan: Japan is making significant strides in the multimodal imaging market by leveraging its technological expertise. The country is known for its innovation in medical imaging technologies, with companies developing advanced PET/MR and SPECT/CT systems. Recent government initiatives to improve healthcare services and promote early diagnosis of diseases are driving the adoption of multimodal imaging systems. Research collaborations between Japanese universities and medical device companies are resulting in the development of state-of-the-art imaging solutions that offer high precision and reliability.
• India: In India, the multimodal imaging market is growing due to increasing healthcare awareness and the rising demand for advanced diagnostic tools. Recent developments include government initiatives to upgrade healthcare infrastructure and provide advanced imaging systems in public hospitals. Indian companies are entering into partnerships with global players to bring the latest multimodal imaging technologies to the market. Efforts to train healthcare professionals in the use of these systems are also underway, ensuring that more patients benefit from early and accurate diagnoses.
Features of the Global Multimodal Imaging Market
Market Size Estimates: Multimodal imaging market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Multimodal imaging market size by technology, application, end use industry, and region in terms of value ($B).
Regional Analysis: Multimodal imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, applications, end use industries, and regions for the multimodal imaging market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the multimodal imaging market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q.1 What is the multimodal imaging market size?
Answer: The global multimodal imaging market is expected to reach an estimated $3.72 billion by 2030.
Q.2 What is the growth forecast for multimodal imaging market?
Answer: The global multimodal imaging market is expected to grow with a CAGR of 4.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the multimodal imaging market?
Answer: The major drivers for this market are increasing prevalence of chronic diseases, growing focus on personalized medicine, and on-going technological advancements in diagnostic imaging modalities.
Q4. What are the major segments for multimodal imaging market?
Answer: The future of the global multimodal imaging market looks promising with opportunities in the brain & neurology, cardiology, oncology, ophthalmology, and research markets.
Q5. Who are the key multimodal imaging market companies?
Answer: Some of the key multimodal imaging companies are as follows:
• Neusoft Medical Systems
• GE Healthcare
• United Imaging Healthcare
• Mediso Medical Imaging
• Siemens Healthineers
• Spectrum Dynamics Medical
• Canon
• Koninklijke Philips N.V.
• Topcon Corporation
• Infraredx
Q6. Which multimodal imaging market segment will be the largest in future?
Answer: Lucintel forecasts that PET/CT will remain the largest segment over the forecast period due to increasing fundings for the multimodal systems and growing need for better turnaround time, high-image resolution, and real-time image guidance during surgeries.
Q7. In multimodal imaging market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to presence of robust healthcare infrastructure, increasing cases of chronic diseases and rising healthcare expenditure in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the multimodal imaging market by technology (PET/CT, PET/MR, SPECT/CT, OCT/FMT, and others), application (brain & neurology, cardiology, oncology, ophthalmology, research applications, and others), end use industry (hospitals, diagnostic imaging centers, research and academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Multimodal Imaging Market, Multimodal Imaging Market Size, Multimodal Imaging Market Growth, Multimodal Imaging Market Analysis, Multimodal Imaging Market Report, Multimodal Imaging Market Share, Multimodal Imaging Market Trends, Multimodal Imaging Market Forecast, Multimodal Imaging Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.